Zimmer Biomet reports Q2 2022 results via press release; details not available in provided filing text

ZIMMER BIOMET HOLDINGS, INC.

2022-Q2 EPS reported $0.80 revenue$3,445,000,000

Press release (Exhibit 99.1) referenced but not appended; specific financial figures cannot be extracted.
Filing indicates results for quarter ended June 30, 2022 were issued on August 2, 2022.
No revenue, EPS, or segment data available in the provided 8-K text.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.